Explore

Trendline Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Reuters Reuters
Vertex tops profit estimates as sales of new cystic fibrosis drug surge

Vertex tops profit estimates as sales of new cystic fibrosis drug surge

May 4 (Reuters) - Vertex Pharmaceuticals on Monday beat Wall Street estimates for first-quarter adjusted profit, helped by a near eight-fold surge in sales of its new cystic fibrosis treatment.
Trendline Trendline
Palantir Technologies Reports Significant Q1 2026 Revenue Growth and Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth and Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth and Raises Full-Year Guidance
Trendline Trendline
GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook

GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook
Trendline Trendline
Berkshire Hathaway Reports 17.7% Increase in Q1 2026 Operating Earnings

Berkshire Hathaway Reports 17.7% Increase in Q1 2026 Operating Earnings

Berkshire Hathaway Reports 17.7% Increase in Q1 2026 Operating Earnings
Trendline Trendline
INOVIO to Announce Q1 2026 Financial Results with Live Webcast

INOVIO to Announce Q1 2026 Financial Results with Live Webcast

INOVIO to Announce Q1 2026 Financial Results with Live Webcast
Trendline Trendline
Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance
Trendline Trendline
V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance

V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance

V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance
Trendline Trendline
V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance

V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance

V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance
Trendline Trendline
NPK International Inc. Reports 16% Revenue Increase in Q1 2026 Amid Strategic Growth Initiatives

NPK International Inc. Reports 16% Revenue Increase in Q1 2026 Amid Strategic Growth Initiatives

NPK International Inc. Reports 16% Revenue Increase in Q1 2026 Amid Strategic Growth Initiatives
Trendline Trendline
PureHealth Achieves Strong Q1 2026 Financial Performance with $2 Billion Revenue

PureHealth Achieves Strong Q1 2026 Financial Performance with $2 Billion Revenue

PureHealth Achieves Strong Q1 2026 Financial Performance with $2 Billion Revenue
Trendline Trendline
Moderna Reports Revenue Growth Amidst Legal Challenges and Regulatory Setbacks

Moderna Reports Revenue Growth Amidst Legal Challenges and Regulatory Setbacks

Moderna Reports Revenue Growth Amidst Legal Challenges and Regulatory Setbacks